REGULATION OF CYTOKINE PRODUCTION BY IL-10 IN ENDOTOXIN-STIMULATED MONOCYTES
内毒素刺激的单核细胞中IL-10对细胞因子产生的调节
基本信息
- 批准号:2568967
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Stimulation of human monocytes with bacterial endotoxin,
lipopolysaccharide (LPS), induces expression of multiple cytokines,
including tumor necrosis factor (TNF-a), interleukin-1 (IL-1b), IL-6 and
IL-10. IL-10 expression is delayed relative to that of TNF-a, IL-1b and
IL-6. Furthermore, IL-10 feedback inhibits expression of TNF-a, IL-1b
and IL-6, thus providing an efficient autocrine mechanism for controlling
proinflammatory cytokine production in monocytes. We have found that the
Th1-type lymphokine, IFN-g, markedly up-regulates production of TNF-a
in endotoxin-stimulated monocytes, and that this potentiation of cytokine
production by IFN-g is due in part to its ability to suppress IL-10
production in monocytes. Nuclear run-on analyses showed that these
effects are transcriptionally-mediated. Thus, potentiation of TNF-a
production by IFN-g in monocytes is coupled to inhibition of endogenous
IL-10 expression (Donnelly et al. 1995. J. Immunol. 155:1420-1427).
In contrast to the effects of IFN-g, IL-10 down-regulates production of
TNF-a in monocytes. In future experiments, we will attempt to define the
mechanism by which IL-10 down-regulates cytokine production, particularly
TNF-a, in activated monocytes. In this context, we will also examine the
cell type specificity of these IL-10-induced effects by comparing the
effects of IL-10 on cytokine production in purified populations of human
monocytes and T cells. In preliminary experiments, we have found that
although IL-10 markedly inhibits production of TNF-a in monocytes, it
does not inhibit expression of TNF-a in activated T cells. To further
define the actions of IFN-g and IL-10 on monocyte functional activities,
we are evaluating the effects of these two cytokines on synthesis and
release of TNF receptors, particularly type-II TNF receptors, by
LPS-stimulated monocytes. TNF-R are shed from monocytes after
stimulation by LPS, and can function as TNF antagonists by competing
with membrane TNF-R (mTNF-R). We have found that IFN-g down-regulates
expression of both mTNF-RII and solubleTNF-RII (sTNF-RII) by
LPS-stimulated monocytes. The decreased production of sTNF-RII in
cultures of IFN-g-treated monocytes correlates directly with decreased
levels of TNF-RII mRNA and inversely with the levels of TNF-a mRNA. In
contrast, IL-10 up-regulates production of sTNF-RII and markedly inhibits
production of TNF-a. IL-10 also blocks the ability of IFN-g to suppress
production of sTNF-RII and to potentiate production of TNF-a. These
findings demonstrate that IL-10 coordinately down-regulates production
of TNF-a (a TNF-R agonist), and up-regulates production of sTNF-RII (a
TNF-R antagonist) in monocytes. IL-10 is currently being tested as a
potential therapeutic agent for the treatment of a number of inflammatory
diseases, including rheumatoid arthritis and Chron's disease. The
results of these studies will enhance our knowledge of the biological
actions of IL-10, and thereby improve our ability to regulate the
clinical use of this biologic agent.
细菌内毒素对人单核细胞的刺激作用
脂多糖,诱导多种细胞因子的表达,
包括肿瘤坏死因子(TNF-a)、白介素1(IL-1b)、IL-6和
IL-10。IL-10的表达相对于肿瘤坏死因子-a、IL-1b和
IL-6。IL-10反馈抑制肿瘤坏死因子-a、IL-1b的表达
和IL-6,从而提供了一种有效的自分泌机制
单核细胞产生促炎细胞因子。我们发现,
Th1型淋巴因子--干扰素-g显著上调肿瘤坏死因子-a的产生
在内毒素刺激的单核细胞中,这种细胞因子的增强
干扰素-g的产生部分归因于其抑制IL-10的能力
在单核细胞中产生。核运行分析表明,这些
影响是由转录调节的。因此,肿瘤坏死因子-a的增强作用
单核细胞产生干扰素-g与内源性抑制有关
IL-10的表达(Donnelly et al.1995年。J.免疫。155:1420-1427)。
与干扰素-g的作用不同,IL-10下调
单核细胞中的肿瘤坏死因子-α。在未来的实验中,我们将尝试定义
IL-10下调细胞因子产生的机制,特别是
活化的单核细胞中的肿瘤坏死因子-α。在这方面,我们还将研究
通过比较IL-10诱导的这些效应的细胞类型特异性
IL-10对人纯种细胞产生细胞因子的影响
单核细胞和T细胞。在初步实验中,我们发现
尽管IL-10显著抑制单核细胞产生肿瘤坏死因子-α,但它
不抑制活化T细胞中肿瘤坏死因子-α的表达。为了进一步
明确干扰素-g和白介素10对单核细胞功能活动的作用,
我们正在评估这两种细胞因子对合成和
释放肿瘤坏死因子受体,特别是II型肿瘤坏死因子受体
内毒素刺激单核细胞。单核细胞分泌肿瘤坏死因子受体
内毒素刺激,并可通过竞争发挥肿瘤坏死因子拮抗剂的作用
与膜上的肿瘤坏死因子受体(mtnf-R)。我们已经发现干扰素-g下调了
Mtnf-RII和可溶性肿瘤坏死因子-RII(sTNF-RII)的表达
内毒素刺激单核细胞。人外周血中sTNF-RII的减少
经干扰素-g处理的单核细胞培养与
TNF-RII基因表达水平与肿瘤坏死因子-α基因表达水平呈负相关。在……里面
相反,IL-10上调sTNF-RII的产生,并明显抑制
产生肿瘤坏死因子-α。IL-10也阻断了干扰素-g抑制的能力
产生sTNF-RII,增强肿瘤坏死因子-α的产生。这些
研究结果表明,IL-10协同下调产量
肿瘤坏死因子受体激动剂,并上调sTNF-RII(a
肿瘤坏死因子受体拮抗剂)。IL-10目前正在作为一种
用于治疗多种炎症性疾病的潜在治疗剂
疾病,包括类风湿性关节炎和慢性疾病。这个
这些研究的结果将提高我们对生物的认识
IL-10的作用,从而提高我们调节
这种生物制剂的临床应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R. P DONNELLY其他文献
R. P DONNELLY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R. P DONNELLY', 18)}}的其他基金
REGULATION OF CYTOKINE GENE EXPRESSION IN HUMAN T CELLS BY IL-4 AND IL12
IL-4和IL12对人T细胞中细胞因子基因表达的调节
- 批准号:
6293751 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF HUMAN T CELL FUNCTIONS BY INTERLEUKIN 12 (IL-12)
白细胞介素 12 (IL-12) 对人类 T 细胞功能的调节
- 批准号:
2456633 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF GENE EXPRESSION BY INTERLEUKIN10 IN ENDOTOXIN-STIMULATED HUMAN MONO
内毒素刺激的人单克隆抗体中白细胞介素10对基因表达的调控
- 批准号:
6293756 - 财政年份:
- 资助金额:
-- - 项目类别:
Characterization of Novel Interleukin 10 Related Genes
新型白细胞介素 10 相关基因的表征
- 批准号:
6545298 - 财政年份:
- 资助金额:
-- - 项目类别:
Recombinant Human Interleukin 12 and Cytokine Expression
重组人白细胞介素 12 和细胞因子表达
- 批准号:
6545297 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF GENE EXPRESSION IN HUMAN T CELL BY INTERLEUKIN 12, 1, 18 AND TNF
白细胞介素12、1、18和TNF对人T细胞基因表达的调节
- 批准号:
6101213 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF CYTOKINE PRODUCTION BY IL-10 IN ENDOTOXIN-STIMULATED MONOCYTES
内毒素刺激的单核细胞中IL-10对细胞因子产生的调节
- 批准号:
6101222 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF GENE EXPRESSION IN HUMAN T CELL BY INTERLEUKIN 12, 1, 18 AND TNF
白细胞介素12、1、18和TNF对人T细胞基因表达的调节
- 批准号:
6161275 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Paracrine and autocrine IL-6 as drivers of treatment resistance in medulloblastoma
旁分泌和自分泌 IL-6 作为髓母细胞瘤治疗抵抗的驱动因素
- 批准号:
468060 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Operating Grants
Targeting Autocrine Hepatocyte Growth Factor (HGF) Production as a Therapeutic Modality in Acute Myeloid Leukemia (AML)
靶向自分泌肝细胞生长因子 (HGF) 的产生作为急性髓系白血病 (AML) 的治疗方式
- 批准号:
10589002 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
自分泌和旁分泌足细胞信号会降低老年肾脏的肾小球功能/健康
- 批准号:
10698100 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Elucidating the role of autocrine TNF signaling in maintaining human regulatory T cell identity
阐明自分泌 TNF 信号传导在维持人类调节性 T 细胞身份中的作用
- 批准号:
BB/W001055/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10615236 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Rôle autocrine des exosomes sécrétés par le muscle dans un contexte de diabète de type 2
2 型糖尿病背景下肌肉中外泌体的自分泌作用
- 批准号:
466812 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Studentship Programs
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10296083 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10469480 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
线粒体活性氧在视网膜神经节细胞中充当自分泌神经调节剂
- 批准号:
10157645 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
线粒体活性氧在视网膜神经节细胞中充当自分泌神经调节剂
- 批准号:
10343744 - 财政年份:2021
- 资助金额:
-- - 项目类别:














{{item.name}}会员




